Dr Sarah Fordham
Dr Wei-Yu Lin
Dr Helen Blair
Dr Claire Elstob
Dr Hayden Bell
et al. | Biallelic TET2 mutations confer sensitivity to 5′-azacitidine in acute myeloid leukemia | 2023 |
|
Dr Timothy Barrow
Dr Sirintra Nakjang
Kateryna Bilotkach
Dr Laura Woodhouse
Gesa Junge
et al. | Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemia | 2021 |
|
Dr Wei-Yu Lin
Dr Sarah Fordham
Dr Nicola Sunter
Dr Claire Elstob
Dr Thahira Rahman
et al. | Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia | 2021 |
|
Dr Wei-Yu Lin
Dr Sarah Fordham
Dr Nicola Sunter
Dr Claire Elstob
Dr Yaobo Xu
et al. | Genome-wide association study identifies susceptibility loci for acute myeloid leukemia | 2021 |
|
Dr Paul Milne
Dr Venetia Bigley
Dr Amy Publicover
Sarah Pagan
Dr Helen Marr
et al. | Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia | 2019 |
|
Dr Sarah Fordham
Dr Helen Blair
Dr Claire Elstob
Professor Ruth Plummer
Dr Yvette Drew
et al. | Inhibition of ATR acutely sensitises acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase | 2018 |
|
